Patrick Walravens

Feb 25, 2026

On Feb 25, 2026, DOCN was given a Market Outperform rating by Patrick Walravens, with a target price of 83. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

Feb 12, 2026

VERX was rated Market Outperform by Patrick Walravens on Feb 12, 2026, with a price objective of 37. A bullish response from the market helped close the gap of 23.61 to the target.

Feb 12, 2026

On Feb 12, 2026, Patrick Walravens initiated coverage on PEGA with a Market Outperform rating and target of 78. The stock’s climb of 6.13% since the call highlights the foresight in the rating.

Feb 11, 2026

On Feb 11, 2026, TDC was evaluated by Patrick Walravens, who gave a Market Outperform rating and target of 49. Investors saw limited payoff as shares fell short of the 49 target.

Feb 11, 2026

Patrick Walravens rated FRSH as Market Outperform on Feb 11, 2026, setting a price target of 27. Shares have remained stable near 7.28, leaving the 27 target still in play.

Feb 11, 2026

On Feb 11, 2026, BL was given a Market Outperform rating by Patrick Walravens, with a target price of 70. Despite the Buy call, shares fell from 32.85 to 32.85, challenging the optimistic stance.

Feb 06, 2026

PCTY received a Market Outperform rating from Patrick Walravens on Feb 06, 2026, aiming for 170. The rating hasn’t played out as hoped, with the stock trading 11.94% below expectations.

Feb 05, 2026

On Feb 05, 2026, Patrick Walravens published a Market Outperform outlook on ORCL, with a target of 285. Shares gained 8.42%, underscoring the accuracy of the bullish outlook toward 285.

Jan 29, 2026

Patrick Walravens on Jan 29, 2026 assigned ALKT a Market Outperform rating, with a price target of 40. The call has struggled to gain traction, with shares losing 22.75%.

Dec 30, 2025

TWLO was rated Market Outperform by Patrick Walravens on Dec 30, 2025, with a price objective of 185. This case shows how bullish projections can fail, with the stock now below 118.32.

Dec 23, 2025

On Dec 23, 2025, Patrick Walravens initiated coverage on NAVN with a Market Outperform rating and target of 25. The Buy call has yet to be validated as shares remain 15.70 away from the target.

Dec 10, 2025

Patrick Walravens issued a Market Outperform recommendation for BRZE on Dec 10, 2025, price target set at 68. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Dec 04, 2025

On Dec 04, 2025, CRM was evaluated by Patrick Walravens, who gave a Market Outperform rating and target of 430. Investors saw limited payoff as shares fell short of the 430 target.

Dec 02, 2025

On Dec 02, 2025, MDB was given a Market Outperform rating by Patrick Walravens, with a target price of 475. Despite the Buy call, shares fell from 314.99 to 314.99, challenging the optimistic stance.

Nov 14, 2025

NICE received a Market Outperform rating from Patrick Walravens on Nov 14, 2025, aiming for 200. The rating hasn’t played out as hoped, with the stock trading 16.71% below expectations.

Oct 28, 2025

On Oct 28, 2025, Patrick Walravens published a Market Outperform outlook on SNOW, with a target of 325. Market action contradicted the Buy thesis, as shares slipped to 169.21.

Oct 23, 2025

Patrick Walravens on Oct 23, 2025 assigned SAP a Market Outperform rating, with a price target of 375. The call has struggled to gain traction, with shares losing 28.82%.

Oct 07, 2025

On Oct 07, 2025, Patrick Walravens reaffirmed VIA with a Market Outperform rating, targeting 59. Shares slid 62.13% despite the recommendation, highlighting downside risks.

Oct 03, 2025

DOCU was rated Market Outperform by Patrick Walravens on Oct 03, 2025, with a price objective of 124. This case shows how bullish projections can fail, with the stock now below 43.26.

Aug 04, 2025

On Aug 04, 2025, NOW was evaluated by Patrick Walravens, who gave a Market Outperform rating and target of 1300. Investors saw limited payoff as shares fell short of the 1300 target.

Jun 27, 2025

Patrick Walravens rated CXM as Market Outperform on Jun 27, 2025, setting a price target of 17. The stock has underperformed, dropping 33.86% despite the bullish target of 17.

Mar 13, 2025

On Mar 13, 2025, KLTR was given a Market Outperform rating by Patrick Walravens, with a target price of 4. Despite the Buy call, shares fell from 1.31 to 1.31, challenging the optimistic stance.

Mar 12, 2025

GLBE received a Market Outperform rating from Patrick Walravens on Mar 12, 2025, aiming for 64. The rating hasn’t played out as hoped, with the stock trading 9.26% below expectations.

Mar 11, 2025

On Mar 11, 2025, Patrick Walravens published a Market Outperform outlook on ASAN, with a target of 22. Market action contradicted the Buy thesis, as shares slipped to 7.16.

Feb 21, 2025

On Feb 21, 2025, Patrick Walravens reaffirmed BAND with a Market Outperform rating, targeting 36. Shares slid 18.71% despite the recommendation, highlighting downside risks.

Jan 27, 2025

On Jan 27, 2025, AMT was evaluated by Patrick Walravens, who gave a Market Outperform rating and target of 225. So far, the Buy call awaits clearer momentum, with shares flat at 182.48.

Dec 16, 2024

Patrick Walravens rated IAC as Market Outperform on Dec 16, 2024, setting a price target of 70. The stock has underperformed, dropping 17.12% despite the bullish target of 70.

Dec 16, 2024

On Dec 16, 2024, Patrick Walravens initiated coverage on GRND with a Market Outperform rating and target of 21. The Buy call has yet to be validated as shares remain 9.82 away from the target.

Dec 16, 2024

Patrick Walravens issued a Market Outperform recommendation for OPAD on Dec 16, 2024, price target set at 4.5. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.